Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 3016 AL 3030

Sternocleidomastoid muscle hypertrophy in cervical dystonia: An unexpected twist

Kannarkat GT, Arthur K, Cross C, Venkatesan A.

Neurol Clin Pract. 2019 Dec;9(6):530-531. doi: 10.1212/CPJ.0000000000000643.

SCN8A Mutation in Infantile Epileptic Encephalopathy: Report of Two Cases

Fatema K, Rahman MM, Faruk O.

J Epilepsy Res. 2019 Dec 31;9(2):147-151. doi: 10.14581/jer.19017. eCollection 2019 Dec.

Protective Effects of the Caffeine Against Neurodegenerative Diseases

Tellone E, Galtieri A, Russo A, Ficarra S.

Curr Med Chem. 2019;26(27):5137-5151. doi: 10.2174/0929867324666171009104040.

The Italian National Rare Diseases Registry: a model of comparison and integration with Hospital Discharge Data

Kodra Y, Minelli G, Rocchetti A, Manno V, Carinci A, Conti S, Taruscio D; National Rare Diseases Registry Collaborating Group.

J Public Health (Oxf). 2019 Mar 1;41(1):46-54. doi: 10.1093/pubmed/fdx176.

Role of Autophagy in Parkinson's Disease

Cerri S, Blandini F.

Curr Med Chem. 2019;26(20):3702-3718. doi: 10.2174/0929867325666180226094351.

Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson's Disease and Huntington's Disease: A Review

Jamwal S, Kumar P.

Curr Neuropharmacol. 2019;17(2):165-175. doi: 10.2174/1570159X16666180302115032.

Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential

Fan D, Liu L, Wu Z, Cao M.

Curr Neuropharmacol. 2019;17(6):563-579. doi: 10.2174/1570159X16666180419141613.

Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 1: Overview of the Chemical and Biological Research

Jankowska A, Świerczek A, Wyska E, Gawalska A, Bucki A, Pawłowski M, Chłoń-Rzepa G.

Curr Drug Targets. 2019;20(1):122-143. doi: 10.2174/1389450119666180808105056.

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV.

Physiol Rev. 2019 Jan 1;99(1):21-78. doi: 10.1152/physrev.00050.2017.

Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases

Sharma S, Sarathlal KC, Taliyan R.

CNS Neurol Disord Drug Targets. 2019;18(1):11-18. doi: 10.2174/1871527317666181004155136.

Phenytoin Induced Chorea: A Rare Adverse Effect of the Drug

Patel DM, Gurumukhani JK, Patel MV, Patel GR.

Curr Drug Saf. 2019;14(1):51-52. doi: 10.2174/1574886313666181031161215.

Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies

Hamed SA.

Expert Rev Clin Pharmacol. 2019 Jan;12(1):61-90. doi: 10.1080/17512433.2019.1555468. Epub 2019 Jan 11.

Multitarget therapeutic strategies for Alzheimer's disease

Ibrahim MM, Gabr MT.

Neural Regen Res. 2019 Mar;14(3):437-440. doi: 10.4103/1673-5374.245463.

Gene Therapy for Neurodegenerative Diseases

Sudhakar V, Richardson RM.

Neurotherapeutics. 2019 Jan;16(1):166-175. doi: 10.1007/s13311-018-00694-0.

Quantum Dots as Promising Theranostic Tools Against Amyloidosis: A Review

Prabhu MPT, Sarkar N.

Protein Pept Lett. 2019;26(8):555-563. doi: 10.2174/0929866526666181212113855.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias